Doctor Reveals The MOST POWERFUL GLP-1 Yet — Retatrutide Phase 3 Results (28.7% Weight Loss)
Dr. Jones, DC — Doctor Reveals The MOST POWERFUL GLP-1 Yet — Retatrutide Phase 3 Results (28.7% Weight Loss)
Channel: Dr. Jones, DC · Our label: Chiropractor / clinician creator · Source: youtube.com/watch?v=mWz-LEYx5YU
What this video covers
Before we start, there is some breaking news. Phase three results have just dropped and I [clears throat] need to give you guys an update. That’s the highest weight loss that’s ever been recorded in a controlled obesity trial. But here’s what else came out that’s a little interesting, little concerning.
Summary drawn from this video’s own transcript (banked in our research library, pulled 2026-11-07). Claims below are the speaker’s — attributed, not endorsed. This site publishes no dosing, protocol, or sourcing information.
Key points, in the speaker’s own framing
- Jones DC and I run the coaching department for a nationwide GLP1 tele medicine practice where I work alongside our prescribing physicians helping patients navigate these exact decisions.
- And in clinical trials, people lost about 15% of their body weight.
- The phase 2 trial, that’s the mid-stage testing before FDA approval can happen after phase three, was published in the New England Journal of Medicine in 2023.
- Plus, Trespatide is FDA approved with years of safety data.
- You want an FDA approved medication with established safety data, and you can optimize with fat mobilization support like AODD if you want that metabolic boost.
- So, maybe we address that, some metabolic support, maybe your inflammation is high because you have inflammatory or autoimmune conditions, and there’s peptides for that too as well.
Read next
Educational information only — not medical advice. Peptides discussed on this page include substances that are not FDA-approved.